DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 204 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $14,112,000 | -52.7% | 700,000 | -12.5% | 0.32% | -47.9% |
| Q2 2021 | $29,856,000 | +46.0% | 800,000 | 0.0% | 0.61% | +67.9% |
| Q1 2021 | $20,456,000 | +85.7% | 800,000 | +60.0% | 0.36% | -15.3% |
| Q4 2019 | $11,015,000 | -23.3% | 500,000 | -50.0% | 0.43% | -26.0% |
| Q3 2019 | $14,360,000 | -8.8% | 1,000,000 | 0.0% | 0.58% | -9.6% |
| Q2 2019 | $15,750,000 | +9.8% | 1,000,000 | +2.1% | 0.64% | +8.7% |
| Q1 2019 | $14,346,000 | +155.6% | 979,275 | +86.5% | 0.59% | +181.7% |
| Q4 2018 | $5,612,000 | -13.5% | 525,000 | +23.5% | 0.21% | +23.1% |
| Q3 2018 | $6,486,000 | +24.6% | 425,000 | 0.0% | 0.17% | +52.3% |
| Q2 2018 | $5,206,000 | +28.1% | 425,000 | 0.0% | 0.11% | +117.6% |
| Q1 2018 | $4,063,000 | – | 425,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,813,392 | $67,676,000 | 17.58% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $114,954,000 | 7.53% |
| RTW INVESTMENTS, LP | 7,521,859 | $280,716,000 | 4.24% |
| DAFNA Capital Management LLC | 510,756 | $19,061,000 | 3.99% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 229,892 | $8,580,000 | 3.83% |
| Parkman Healthcare Partners LLC | 304,686 | $11,371,000 | 2.49% |
| Evolutionary Tree Capital Management, LLC | 141,324 | $5,274,000 | 2.43% |
| Eagle Health Investments LP | 161,125 | $6,013,000 | 2.06% |
| Lombard Odier Asset Management (Switzerland) SA | 636,011 | $23,736,000 | 1.20% |
| Woodline Partners LP | 1,000,325 | $37,332,000 | 0.70% |